The Wegovy pill's approval signifies a shift from injectable to oral dosage forms, driven by patient preference for ...

In today’s Pharmaceutical Executive Daily, the FDA approves Novo Nordisk’s oral Wegovy for chronic weight management, clears ...

Bengaluru: Strides Pharma Science has announced that the U.S. Food and Drug Administration (USFDA) has concluded inspection ...

But Eli Lilly's Zepbound is best in class. Zepbound caused greater average weight loss than Wegovy in a head-to-head study. And through the first nine months of 2025, Zepbound generated $9.3 billion ...

Strides Pharma Science Ltd's Chestnut Ridge facility received four procedural FDA observations, with no impact on supply.

Three years after its initial FDA approval, Roche has made up for an early disadvantage with its blood cancer drug Lunsumio ...

Novo Nordisk said it plans to start selling the new pill in the U.S. soon after the new year, with a cash price of $149 a ...

Japanese skincare brand Yii is collaborating with ANDS Corporation (hereinafter 'ANDS'), an affiliate of Rohto Pharmaceutical Co., Ltd., to explore the niche skincare market with pharmaceutical-grade ...

Novo Nordisk's ADRs rose 8% higher to $51.99 in post-market trading on volume that topped 1.2 million ADRs. The stock ended the day's market session little changed at $48.10. The approval makes Wegovy ...

Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma", “Nasus” or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency ...

The inspection was conducted from December 15 to December 19, 2025, and concluded with five observations related to ...